Citation Impact
Citing Papers
Oxidative Stress
2017 Standout
Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression
2006 Standout
The discovery and development of HMG-CoA reductase inhibitors.
1992
Transcriptional regulation of macrophage polarization: enabling diversity with identity
2011 Standout
Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E–deficient mice
1999
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Effect of Simvastatin, Ursodeoxycholic Acid and Simvastatin Plus Ursodeoxycholic Acid on Biliary Lipid Secretion and Cholic Acid Kinetics in Nonfamilial Hypercholesterolemia
1992
The re-emergence of natural products for drug discovery in the genomics era
2015 Standout
Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator–activated receptor γ
2000
Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E- deficient mouse hepatocytes.
1997
Pro-resolving lipid mediators are leads for resolution physiology
2014 StandoutNature
Transfer of 15-lipoxygenase gene into rabbit iliac arteries results in the appearance of oxidation-specific lipid-protein adducts characteristic of oxidized low density lipoprotein.
1995
Estrogen receptor α is a major mediator of 17β-estradiol’s atheroprotective effects on lesion size in Apoe–/– mice
2001 StandoutNobel
Low-Density Lipoprotein Receptor-Related Protein-1 Mediates Endocytic Clearance of Tissue Inhibitor of Metalloproteinases-1 and Promotes Its Cytokine-Like Activities
2014 StandoutNobel
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
Macrophage-specific expression of group IIA sPLA2 results in accelerated atherogenesis by increasing oxidative stress
2005
Oxysterols and atherosclerosis
1999
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
2008 Standout
A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease
1995 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
2007 StandoutNature
Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development.
1996
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
The immune system in atherosclerosis
2011 Standout
Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase
1999 Nature
Long-term endocrine function in hypercholesterolemic patients treated with pravastatin, a new 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor
1993
Effect of Vitamin E and Probucol on Dietary Cholesterol-Induced Atherosclerosis in Rabbits
1998
Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice
2000
Reduction in Levels of 24S-Hydroxycholesterol by Statin Treatment in Patients With Alzheimer Disease
2003
Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity
2012 Standout
The immune response in atherosclerosis: a double-edged sword
2006 Standout
Oxidation of Free Fatty Acids in Low Density Lipoprotein by 15-Lipoxygenase Stimulates Nonenzymic, α-Tocopherol-mediated Peroxidation of Cholesteryl Esters
1997
The Benefits of Frequent Positive Affect: Does Happiness Lead to Success?
2005 Standout
In vivo action of 15-lipoxygenase in early stages of human atherogenesis.
1997
Oxidants, oxidative stress and the biology of ageing
2000 StandoutNature
Minimally Modified LDL Binds to CD14, Induces Macrophage Spreading via TLR4/MD-2, and Inhibits Phagocytosis of Apoptotic Cells
2003
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
1996 Standout
Atherosclerosis — An Inflammatory Disease
1999 Standout
Alzheimer's Disease
2010 Standout
Attenuation of diet‐induced atherosclerosis in rabbits with a highly selective 15‐lipoxygenase inhibitor lacking significant antioxidant properties
1997
Association of apolipoprotein E polymorphism with blood lipids and maximal oxygen uptake in the sedentary state and after exercise training in the HERITAGE family study
2003
Biochemistry and molecular cell biology of diabetic complications
2001 StandoutNature
The Oxidation of Lipoproteins by Monocytes-Macrophages
1999
The Oxidative Modification Hypothesis of Atherosclerosis Does It Hold for Humans?
2001
Defined daily doses in relation to hypolipidaemic efficacy of lovastatin, pravastatin, and simvastatin
1994
Atherosclerosis
2000 StandoutNature
LDL Receptor-Related Protein 1: Unique Tissue-Specific Functions Revealed by Selective Gene Knockout Studies
2008
Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040
2014 Standout
Combined Serum Paraoxonase Knockout/Apolipoprotein E Knockout Mice Exhibit Increased Lipoprotein Oxidation and Atherosclerosis
2000 Standout
Cell-mediated oxidation of low-density lipoprotein: the elusive mechanism(s)
1996
Atherosclerosis
2001 Standout
Alternative activation of macrophages
2003 Standout
Roles of PPARs in health and disease
2000 StandoutNature
Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis
1998
Metabolomics in the context of systems biology: bridging traditional Chinese medicine and molecular pharmacology
2005
Can antioxidant vitamins materially reduce oxidative damage in humans?
1999
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
2010 Standout
Essential Roles of Lipoxygenases in LDL Oxidation and Development of Atherosclerosis
2005
Minimally Oxidized Low-Density Lipoprotein Increases Expression of Scavenger Receptor A, CD36, and Macrosialin in Resident Mouse Peritoneal Macrophages
1998
Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory, Musculoskeletal, and Neuromotor Fitness in Apparently Healthy Adults
2011 Standout
HEALTH PSYCHOLOGY: Mapping Biobehavioral Contributions to Health and Illness
1999
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
2003 Standout
Transcriptional regulation of adipogenesis
2000 Standout
Apolipoprotein E: Far More Than a Lipid Transport Protein
2000
Increased Cardiac Sympathetic Activity and Oxidative Stress in Habitual Electronic Cigarette Users
2017
Fat and Beyond: The Diverse Biology of PPARγ
2008 Standout
Total Synthesis of α-Pyrone Meroterpenoids, Novel Bioactive Microbial Metabolites
2005 StandoutNobel
Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves
2009 StandoutNobel
Oxysterols: Modulators of Cholesterol Metabolism and Other Processes
2000
12/15-Lipoxygenase Gene Disruption Attenuates Atherogenesis in LDL Receptor–Deficient Mice
2001
Lipoperoxides in LDL incubated with fibroblasts that overexpress 15-lipoxygenase.
1995
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
2001 StandoutScience
Alternative Activation of Macrophages: An Immunologic Functional Perspective
2008 Standout
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Oxidation of LDL by rabbit and human 15-lipoxygenase: prevalence of nonenzymatic reactions
2001
Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors
1998 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Regulation of Peroxisome Proliferator-Activated Receptor γ Expression by Adipocyte Differentiation and Determination Factor 1/Sterol Regulatory Element Binding Protein 1: Implications for Adipocyte Differentiation and Metabolism
1999
Cytokine Modulation of LDL Oxidation by Activated Human Monocytes
1997
Apolipoprotein E Alleles, Dyslipidemia, and Coronary Heart Disease
1994
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
1999 Standout
[The Rotterdam study].
2011
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Cholesterol Synthesis Inhibition Elicits an Integrated Molecular Response in Human Livers Including Decreased ACAT2
2008 StandoutNobel
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Role of Monocytes in Atherogenesis
2003
Interleukin-4 augments acetylated LDL-induced cholesterol esterification in macrophages
2000
12/15-Lipoxygenase, Oxidative Modification of LDL and Atherogenesis
2001
Absence of 12/15-Lipoxygenase Expression Decreases Lipid Peroxidation and Atherogenesis in Apolipoprotein E–Deficient Mice
2001
Oxidation of LDL by recombinant human 15-lipoxygenase: evidence for alpha-tocopherol-dependent oxidation of esterified core and surface lipids
1996
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia
2006 Standout
Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans.
1988
Works of M.J.T.M. Mol being referenced
Enhanced Levels of Lipoperoxides in Low Density Lipoprotein Incubated with Murine Fibroblasts Expressing High Levels of Human 15-Lipoxygenase
1995
Simvastatin (MK-733): a potent cholesterol synthesis inhibitor in heterozygous familial hypercholesterolaemia
1988
EFFECTS OF INHIBITION OF CHOLESTEROL SYNTHESIS BY SIMVASTATIN ON THE PRODUCTION OF ADRENOCORTICAL STEROID HORMONES AND ACTH
1989
Plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and cigarette smoking: effects of vitamin E treatment
1997
Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice.
1996
Macrophage oxidative modification of low density lipoprotein occurs independently of its binding to the low density lipoprotein receptor
1996
Both Lipolysis and Hepatic Uptake of VLDL Are Impaired in Transgenic Mice Coexpressing Human Apolipoprotein E*3Leiden and Human Apolipoprotein C1
1996
The role of modification of lipoproteins and of the immune system in early atherogenesis.
1993
Influence of apo E polymorphism on the response to simvastatin treatment in patients with heterozygous familial hypercholesterolemia
1990
EFFECTS OF SYNVINOLIN (MK-733) ON PLASMA LIPIDS IN FAMILIAL HYPERCHOLESTEROLAEMIA
1986